Celltrion Secures Deal With PBM Express Scripts For Subcutaneous Infliximab

The Agreement Gives The Drug Access To Nearly 22 Million Patients In The US

Celltrion website homepage. Celltrion logo
• Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products